<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-13-32</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-13-4-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurocutaneous Syndromes</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Late Neurologic Complications of Neurofibromatosis I</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>04</month>
<year>1999</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>05</month>
<year>2016</year>
</pub-date>
<volume>13</volume>
<issue>4</issue>
<fpage>32</fpage>
<lpage>33</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1999 The Author(s)</copyright-statement>
<copyright-year>1999</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1093/brain/122.3.473" vol="122" page="473">
<article-title>Neurological complications of neurofibromatosis type 1 in adulthood</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>A hospital-based series of 158 patients with neurofibromatosis I, including 138 adults aged >18 years and 20 children, were evaluated for neurological complications in adulthood at the Services de Neurologie and Neuroradiologie, Hopital Henri Mondor, Paris, France.</p>
</abstract>
<kwd-group>
<kwd>Neurofibromatosis I</kwd>
<kwd>Neuroradiologie</kwd>
<kwd>Intraspinal Neurofibroma</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>A hospital-based series of 158 patients with neurofibromatosis I, including 138 adults aged >18 years and 20 children, were evaluated for neurological complications in adulthood at the Services de Neurologie and Neuroradiologie, Hopital Henri Mondor, Paris, France. Neurological manifestations observed in 87 (55%) of patients (both children and adults) included headache (28 patients), hydrocephalus (7), epilepsy (5), lacunar stroke (1), white matter disease (1), intraspinal neurofibroma (3), facial palsy (1), radiculopathy (5), and polyneuropathy (2). Tumors included: optic pathway (20), meningioma (2), cerebral glioma (3), and malignant peripheral nerve sheath tumors (6). Pain related to nerve and spinal tumors occurring in 11 adults, and malignant nerve tumors were found predominantly in adults. Optic pathway tumors, cerebral gliomas, aqueductal stenosis, and spinal compression were childhood-related complications. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. The authors recommend follow-up with serial ophthalmological examination rather than repetitive neuroimaging in adults with neurofibromatosis 1 (NF1). This policy agrees with that of Listernick and colleagues at Children&#x2019;s Memorial Hospital, Chicago, who find that serial MRIs are of limited value in asymptomatic children. [<xref ref-type="bibr" rid="CIT0002">2</xref>]</p>
<p>In adult patients with NF1, disabling and life-threatening neurological complications, except for malignant peripheral nerve sheath tumors, are usually absent, and chronic painful symptoms related to nerve and spinal tumors are the chief neurologic complications. In contrast, children with NF1 are at greatest risk of optic pathway tumors, especially in the first 6 years of life. Tumor growth after 6 years is unusual. Other neurologic complications of NF1 in childhood include infantile spasms, CVA, and learning disabilities. For further references to NF1, see <underline>Progress in Pediatric Neurology III.</underline> PNB Publ, 1997;pp439-442; Vol II, 1994;362.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cr&#x00E9;ange</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zeller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rostaing-Rigattieri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brugi&#x00E8;res</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Degos</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Revuz</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Neurological complications of neurofibromatosis type 1 in adulthood</article-title>
<source>Brain</source>
<year>1999</year>
<month>Mar</month>
<volume>122</volume>
<issue>Pt 3</issue>
<fpage>473</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1093/brain/122.3.473</pub-id>
<pub-id pub-id-type="pmid">10094256</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Listernick</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Charrow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Greenwald</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mets</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Natural history of optic pathway tumors in children with neurofibromatosis type, a longitudinal study</article-title>
<source>J Pediatr</source>
<year>1994</year>
<month>Jul</month>
<volume>125</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(94)70122-9</pub-id>
<pub-id pub-id-type="pmid">8021787</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>